Medical News

RSS

Despite simmering GOP rage on health bill, some Republicans say they can still work with Democrats

NPR reports: "Though conservative anger with Washington over the newly signed bill has been particularly hot, some longtime political observers see a revival of previous populist movements from the right. ... Chip Berlet with Political Research Associates, a liberal group that tracks populist anti-government movements, says this is nothing new.

31 Mar 2010

Titan Pharmaceuticals commences Phase 3 study of Probuphine for opioid addiction

Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).

31 Mar 2010

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Ikaria Holdings, Inc. announced today that it has acquired the New Drug Application (NDA) and the Investigational New Drug (IND) application to LUCASSIN® (terlipressin for injection) from Orphan Therapeutics, assuming all future development and ownership of the drug in North America and Australia.

31 Mar 2010

Coastal Contacts announces loan agreement with Bank of America

Coastal Contacts Inc. today announced that it has entered into a loan agreement with the Bank of America for a $5 million secured revolving line of credit.

31 Mar 2010

Hospira acquires Orchid's injectables formulations business

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.

31 Mar 2010

SpineAlign Medical announces VerteLift as new name for vertebral implant system

SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.

30 Mar 2010

MedeAnalytics' white paper focuses on potential reductions of annual updates to the IPPS

MedeAnalytics, a leading provider of healthcare performance management solutions, today released a white paper on one of the HITECH Act's measures designed to motivate hospitals to become meaningful users of electronic health records (EHRs): potential negative adjustments to Medicare's market basket updates to the Inpatient Prospective Payment System (IPPS).

30 Mar 2010

CLC bio signs partnership agreement with Ion Torrent

CLC bio, the world's leading bioinformatics solution provider, today announced a partnership with Ion Torrent, a new sequencing company started by Dr. Jonathan Rothberg, the founder of 454 Life Sciences. The partnership will ensure that data can directly flow off of the Ion Personal Genome Machine sequencer and into CLC bio's solutions, like CLC Genomics Workbench or CLC Genomics Server.

30 Mar 2010

FDA allows GeoVax Labs to commence phase 1 clinical trial for HIV/AIDS therapeutic vaccine

GeoVax Labs, Inc., a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA to begin a phase 1 clinical trial for GeoVax's therapeutic vaccine, which is intended as a treatment for individuals infected with HIV. The company will begin a non-blinded study in HIV infected individuals who started drug treatment during their first year of infection.

30 Mar 2010

Multi-center clinical trial of MyoSure Hysteroscopic Tissue Removal System initiated

Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.

30 Mar 2010

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.

30 Mar 2010

Novo Nordisk BlueSheet launched to provide information on diabetes and chronic disease

Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.

30 Mar 2010

Ascent Therapeutics is now Anchor Therapeutics

Ascent Therapeutics announced today that it has adopted a new name — Anchor Therapeutics. Anchor Therapeutics reflects the Company's core technology and its commitment to building solid, dependable value for patients, partners and investors via its proprietary platform technology.

30 Mar 2010

CTRC initiates patient enrolment in U.S. Phase 2 clinical trial of REOLYSIN

Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with carboplatin and paclitaxel in patients with squamous cell carcinoma of the lungs.

30 Mar 2010

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).

30 Mar 2010

Savient Pharmaceuticals' resubmission of BLA for KRYSTEXXA accepted for FDA review

Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has acknowledged receipt of and accepted for review the March 15, 2010 resubmission of the Biologics License Application for KRYSTEXXA™ (pegloticase), a treatment for chronic gout in patients refractory to conventional therapy.

30 Mar 2010

Neuroscientists prevent memory loss in fruit flies by blocking activity of PI3 kinase signaling protein

By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans. The study also resolves a long-standing controversy about the role of this protein, PI3 kinase, which was previously thought to have a protective function against the disease.

30 Mar 2010

Seniors at Springhill retirement community find a secret to stay young and active

Seniors at Springhill retirement community have found a secret to staying young and active—HealthAbility. Springhill resident Joe Bertoncini, 88, has always been active, with 64 Senior Olympic medals over the past 14 years. He says the HealthAbility program has helped him to build on those healthy results.

30 Mar 2010

The Sports Club's operating revenues for fourth-quarter 2009 decrease by 16.3%

The Sports Club Company, Inc. today announced financial results for the fourth quarter and year ended December 31, 2009.

30 Mar 2010

Genetically manipulating rats to emulate Alzheimer's disease in humans

Prof. Claudio Cuello at McGill University and his collaborators have genetically manipulated rats that can emulate Alzheimer's disease in humans, enabling research that will include the development of new treatments. Alzheimer's is a devastating brain condition leading to a progressive decline of memory and other brain functions. Although research mice have been developed in the past, rats are more intelligent than other rodents and the behavior of these rats is rich and predictable, which means that for the first time researchers will be able to detect and study the evolution of learning and memory deficits.

30 Mar 2010

Medical News

Despite simmering GOP rage on health bill, some Republicans say they can still work with Democrats

Titan Pharmaceuticals commences Phase 3 study of Probuphine for opioid addiction

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Coastal Contacts announces loan agreement with Bank of America

Hospira acquires Orchid's injectables formulations business

SpineAlign Medical announces VerteLift as new name for vertebral implant system

MedeAnalytics' white paper focuses on potential reductions of annual updates to the IPPS

CLC bio signs partnership agreement with Ion Torrent

FDA allows GeoVax Labs to commence phase 1 clinical trial for HIV/AIDS therapeutic vaccine

Multi-center clinical trial of MyoSure Hysteroscopic Tissue Removal System initiated

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

Novo Nordisk BlueSheet launched to provide information on diabetes and chronic disease

Ascent Therapeutics is now Anchor Therapeutics

CTRC initiates patient enrolment in U.S. Phase 2 clinical trial of REOLYSIN

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Savient Pharmaceuticals' resubmission of BLA for KRYSTEXXA accepted for FDA review

Neuroscientists prevent memory loss in fruit flies by blocking activity of PI3 kinase signaling protein

Seniors at Springhill retirement community find a secret to stay young and active

The Sports Club's operating revenues for fourth-quarter 2009 decrease by 16.3%

Genetically manipulating rats to emulate Alzheimer's disease in humans

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News